Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.46 - $0.78 $121 - $206
265 New
265 $0
Q4 2023

Feb 14, 2024

SELL
$0.38 - $0.82 $36 - $78
-96 Reduced 82.05%
21 $0
Q2 2023

Aug 14, 2023

SELL
$0.98 - $1.11 $237 - $268
-242 Reduced 67.41%
117 $0
Q1 2023

May 12, 2023

BUY
$0.98 - $1.06 $192 - $207
196 Added 120.25%
359 $0
Q4 2022

Feb 10, 2023

SELL
$0.96 - $28.0 $75 - $2,212
-79 Reduced 32.64%
163 $0
Q3 2022

Nov 14, 2022

SELL
$1.06 - $27.75 $1,303 - $34,132
-1,230 Reduced 83.56%
242 $0
Q2 2022

Aug 12, 2022

SELL
$1.07 - $1.55 $63,489 - $91,970
-59,336 Reduced 97.58%
1,472 $1,000
Q1 2022

May 16, 2022

SELL
$1.21 - $2.24 $2,787 - $5,160
-2,304 Reduced 3.65%
60,808 $89,000
Q4 2021

Feb 08, 2022

BUY
$2.02 - $3.36 $114,594 - $190,612
56,730 Added 888.91%
63,112 $136,000
Q3 2021

Nov 15, 2021

BUY
$2.96 - $36.67 $5,644 - $69,929
1,907 Added 42.61%
6,382 $19,000
Q2 2021

Sep 13, 2021

BUY
$31.5 - $42.5 $140,962 - $190,187
4,475 New
4,475 $150,000

Others Institutions Holding FBRX

# of Institutions
1
Shares Held
175K
Call Options Held
0
Put Options Held
0

About Forte Biosciences, Inc.


  • Ticker FBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,340,300
  • Market Cap $466M
  • Description
  • Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
More about FBRX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.